English
联系我们
网站地图
邮箱
旧版回顾



舞动奇迹

捷豹路虎砍开支保揽胜 卫士换代被按暂停键_我的网站

小产权房

A |     

Coronavirus is on the rise in the U.S., prompting questions about when Americans can roll up their sleeves for the next COVID-19 vaccine.
COVID-19 hospitalizations have been increasing for six straight weeks. While levels remain far below previous coronavirus waves in the U.S., it’s still the first increase since winter, and it has even prompted the return of mask mandates for a handful of businesses and schools.
The Biden administration estimates that 97% of Americans ages 16 and over have some level of COVID-19 immunity through vaccination, previous infection or both. The number may sound promising – so why do people need another round of shots? Because that protection can fade in a matter of months, leaving individuals vulnerable to COVID-19 once again.
“Immunity is stronger today than at any other point in the outbreak,” Mandy Cohen, the director of the Centers for Disease Control and Prevention, said in a recent video statement. “That means we're moving towards COVID-19 being a more manageable illness with less severe illness. Having antibodies is like a shield, but we still need to be cautious because that protection does decrease over time.”
When Will the Shots Be Available?
Rollout of the shots is expected in mid-September, according to officials with the CDC and the Food and Drug Administration.
The shots from Moderna, Pfizer and Novavax first need authorization from the FDA. After that, the CDC’s committee of outside vaccine experts will gather to recommend who should be eligible for the shots. That meeting is scheduled for Sept. 12. Then, the CDC director must sign off on the recommendations before shots can be administered.
For undervaccinated or unvaccinated Americans – especially those who are at high risk for severe disease – Cohen says it might be best for them to roll up their sleeves now for the shots that are currently available.
“Those who have never been vaccinated and then some people who are older and at higher risk for a COVID infection might be best to get the existing COVID shot now and not wait,” Cohen said, noting that individuals should talk to their doctor first.
But Cohen added that “if you do get the current COVID-19 vaccine now or in early September, it could delay your ability to get this updated vaccine that's coming out in the middle of September.”
Will the Updated Boosters Work on New Coronavirus Variants?
The updated shots target XBB.1.5, which was responsible for less than 5% of new coronavirus infections in recent weeks.
The variant scene has changed significantly since the Biden administration advised vaccine makers to target the XBB strain in June. Now, EG.5, or “eris,” is the dominant strain circulating, causing over 20% of new cases.
But all the strains circulating are still descendants of omicron, so experts believe the shots will still protect against severe COVID-19 from the variants.
A Biden administration official told reporters last week, “FDA expects that once available, the updated vaccines will similarly provide protection against the most serious outcomes of the disease that may result from currently circulating variants.”
Additionally, experts are keeping a close eye on how BA.2.86, a new strain that is highly mutated, could affect the shots.
“The CDC is closely tracking a new variant which does have a number of changes or mutations that do make it distinct and different from the older versions of the virus,” Cohen said. “So we're working as fast as we can to understand this new variant and what impact it might have on how severe the COVID disease will get or how well our vaccines work against it.”
Will the New COVID-19 Shot Be Free?
Most Americans will receive the shot cost-free through their insurance. For uninsured Americans, the Biden administration is working on a program that will offer free shots at pharmacies. That program might not be available on the same day the shots are authorized but is expected to be up and running within a couple of weeks of the date.
Uninsured Americans will have immediate access to the shots for free at community health centers and individual providers as soon as they roll out.
How Many People Will Get a Booster Shot?
Historically, vaccine uptake decreases each time a new coronavirus shot is offered.
Just 17% of Americans as of May rolled up their sleeves for the latest round of shots offered. That’s a steep drop from the first shot, which saw 81% of the population roll up their sleeves.
But there are reasons to be hopeful that uptake of the shots could be higher this time around. A survey from KFF found that more than half of adults said they are likely to get another COVID-19 booster shot if it’s offered annually like the flu shot.
。    8月26日消息,据报道,多方消息称捷豹路虎放慢了卫士全面换代的节奏,下一代卫士纯电版推迟到本世纪30年代,较原计划延后约两年。     不过捷豹路虎并未给出纯电卫士的明确上市时间,也未正式确认30年代这一节点。         捷豹路虎近期向投资者和公司内部发布的信息显示,公司削减了部分开支,把更多资源集中到已经接近量产的车型上。     与此同时,AESC位于桑德兰的电池工厂扩建计划也出现延迟,该工厂此前被认为与捷豹路虎的电池供应谈判相关,这进一步影响了纯电卫士的推进节奏。    捷豹路虎首席商务官Lennard Hoornik曾透露,将现款卫士电气化远比听起来复杂,现有平台根本不适合在不做出重大妥协的情况下适配电动动力系统。这意味着纯电卫士需要等待全新平台开发,而非简单改造现款车型。    在产品规划方面,捷豹路虎已确认纯电揽胜和纯电揽胜运动版将采用纵向模块化架构(MLA),在索利哈尔工厂生产。     首款采用电动模块化架构(EMA)的SUV属于揽胜家族,将在哈利伍德工厂组装。纯电揽胜将在今年晚些时候正式亮相,并于2026至2027财年下半年(对应2026年10月至2027年3月)上市。

B |     值得注意的是,纯电揽胜原定目标是在2024年前后进入展厅,如今已跳票约两年。         经过调整后,纯电揽胜、基于EMA架构打造的全新揽胜车型,以及捷豹的新款纯电车型,已成为捷豹路虎近期最主要的纯电项目。    至于纯电卫士,捷豹路虎至今没有公布其加入上述产品规划的具体时间,也没有确认与合作伙伴在美国生产卫士家族车型的消息,更没有为类似合作给出时间表。    此外,捷豹路虎仍在继续研究一款尺寸更小、沿用卫士设计风格的新车型,即此前规划中的“小卫士”,目前同样没有明确时间表。              

     【本文结束】如需转载请务必注明出处:      责任编辑:霜月     文章内容举报     

Current article:http://wqv3agk.aiwengchuanzuodahuai.shop/list_iu1/p68gql.html

Published on:00:39:00


专题推荐

相关新闻


© 1996 - 我的网站 版权所有   联系我们

地址:北京市三里河路52号 邮编:100864